CD8A and hepatocellular carcinoma: Tregs extracted from the tumor site contribute to uncontrolled growth of HCC cells by inhibiting the proliferation of CD8+ cytotoxic T cells (Fig. 2), leading to poor clinical outcome and poor survival of HCC patients56.